Product logins

Find logins to all Clarivate products below.


Gastrointestinal Endoscopy Devices | Market Insights | Latin America (Supplemental) | 2021

The COVID-19 pandemic will negatively impact the Latin American GI endoscopy device market. Once the market stabilizes, it will grow modestly during the forecast period because of the improving access to healthcare across the region and the concerted efforts of health systems to implement extensive screening programs, especially for CRC. Having said that, the unstable economic conditions in the region, as well as the practice of reusing GI endoscopy devices among health care facilities, will act as limiting factors for the market.

This Medtech 360 Report provides high-level market metrics for the GI endoscopy device market in Latin America, including country-level data for major countries and aggregate data for the rest of Latin America, across a 10-year period.

Related Medtech Insights Reports

Report
Gastrointestinal Endoscopy Devices – Market Insights – Europe
The European GI endoscopy device market will be driven primarily by the high incidence of gastric cancer and CRC in the region. Market growth will be supported by nationwide CRC and GI cancer…
Report
Aesthetic Injectables – Market Insights – Latin America
The Latin American aesthetic injectables market will expand through 2035, driven by ongoing product innovation and differentiation strategies among key competitors, as well as the increasing…
Report
Laparoscopic Devices – Market Insights – Latin America
The Latin American laparoscopic device market will experience steady moderate growth through 2035, supported by the gradual expansion of MIS volumes and selective adoption of highervalue…
Report
Interventional Oncology Devices – Market Insights – Latin America
The Latin American interventional oncology device market will see moderate growth through 2034, driven by a large and rapidly expanding patient pool, improving access to treatment, and the entry of…
Report
Biosurgical Agents – Market Insights – Latin America
The Latin American biosurgical agent market will grow modestly through 2034; although demand for biosurgical agents will rise—supported by favorable regional demographics, expanded indication…